• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯贝丁酯治疗糖尿病伴高蛋白血症(作者译)

[Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].

作者信息

Jung W, Kremer G J, Müller D

出版信息

MMW Munch Med Wochenschr. 1975 Oct 31;117(44):1783-6.

PMID:171564
Abstract

The effect of a six weeks clofibrate treatment on lipid metabolism was investigated in a collective of 38 constantly maladjusted elderly diabetics with an average of 30% overweight and various forms of hyperlipoproteinemias. Clofibrate produced a significant lowering of the mean triglyceride and cholesterol levels, whereas no such effect was observed in an untreated control group. Related to the various types of hyperlipoproteinemia (IIa, IIb and IV), the group treated with clofibrate showed a rate of normalization of nearly 50%, while the rate of improvement in the untreated control group was 10%.

摘要

在一个由38名持续失调的老年糖尿病患者组成的群体中,研究了六周氯贝丁酯治疗对脂质代谢的影响。这些患者平均超重30%,并患有各种形式的高脂蛋白血症。氯贝丁酯使平均甘油三酯和胆固醇水平显著降低,而在未治疗的对照组中未观察到这种效果。与各种类型的高脂蛋白血症(IIa、IIb和IV型)相关,接受氯贝丁酯治疗的组的正常化率接近50%,而未治疗的对照组的改善率为10%。

相似文献

1
[Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].氯贝丁酯治疗糖尿病伴高蛋白血症(作者译)
MMW Munch Med Wochenschr. 1975 Oct 31;117(44):1783-6.
2
[Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].用丁双胍和氯贝丁酯治疗IIB型和IV型原发性高脂蛋白血症(作者译)
MMW Munch Med Wochenschr. 1977 May 20;119(20):701-4.
3
[Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].[原发性高脂蛋白血症的治疗。N 041与氯贝丁酯的比较]
MMW Munch Med Wochenschr. 1976 Sep 3;118(36):1127-30.
4
[Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].安妥明与β-吡啶甲醇联合疗法和安妥明单一疗法的比较(作者译)
MMW Munch Med Wochenschr. 1978 Apr 14;120(15):525-8.
5
[Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].[α-甲基甲状腺素(司克洛诺姆)与氯贝丁酯(利占隆)对IIa/b型和IV型高脂蛋白血症患者降低胆固醇及甘油三酯作用的比较研究]
Verh Dtsch Ges Inn Med. 1977;83:392-5.
6
[Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
Med Klin. 1978 Feb 17;73(7):231-9.
7
Clofibrate and related compounds in hyperlipoproteinaemia. A review.氯贝丁酯及相关化合物治疗高脂蛋白血症。综述。
Postgrad Med J. 1975;51(8):suppl 66-71.
8
[Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
Kardiologiia. 1976 Jul;16(7):71-5.
9
Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).抗脂药物。第5部分:LF 178对191例患致动脉粥样硬化型内源性高脂蛋白血症(IIa型、IIb型和IV型)患者的降血脂作用评估。
Arzneimittelforschung. 1976;26(5):901-6.
10
[Different forms of hyperlipoproteinemia in diabetics (author's transl)].糖尿病患者中高脂蛋白血症的不同形式(作者译)
Med Klin. 1975 Nov 14;70(46):1871-7.

引用本文的文献

1
[Bezafibrate in primary hyperlipidemias (author's transl)].非诺贝特治疗原发性高脂血症(作者译)
Klin Wochenschr. 1982 Jan 15;60(2):97-105. doi: 10.1007/BF01716387.